If you're like me—someone who's been handling surgery equipment orders for a mid-sized hospital for about six years—you've probably fielded the same question from your surgical teams: Should we invest in robotic surgery capability, or stick with traditional open and minimally invasive approaches, especially for something like heart valve replacement?
The short answer is: it depends on what you're optimizing for. But the real answer requires looking at how tools like Conmed laparoscopic instruments and the Conmed Smart Nail surgical technique fit into each approach.
I'm going to walk you through the three dimensions that matter most for our OR procurement decisions—cost per case, training burden, and clinical flexibility—based on what I've seen coordinating about 400+ cardiac and general surgery cases over the last four years. I've made some expensive mistakes along the way (including a $6,000 inventory error in Q2 2023 that I still cringe about), so hopefully, this helps you avoid mine.
The Comparison Framework: Two Paths for the OR
Here's the high-level contrast we're dealing with:
Path A: Traditional Heart Valve Replacement (with Advanced Laparoscopy)
This isn't your 1990s open-heart surgery. A modern valve replacement can be done through a mini-sternotomy or a right anterior thoracotomy, often assisted by Conmed endoscopy systems and their laparoscopic instruments. The surgeon uses a camera and long-shafted tools through small incisions. No robot. Just skilled hands and good optics.
Path B: Robotic Surgery (for Valve and Other Procedures)
A robotic system (like the Da Vinci or comparable platforms) gives the surgeon wristed instruments, 3D high-definition vision, and tremor filtration. The Conmed Smart Nail and other advanced fixation devices can be deployed in this setup, though the integration is more complex.
So, we're not comparing 'old vs. new.' We're comparing two modern approaches where Conmed products can play a role.
The three dimensions we'll measure:
1. Cost Per Case (Capex + Opex)
2. Training & Team Readiness
3. Case Versatility
Dimension 1: Cost Per Case – The Robotic Tax vs. The Instrument Savings
Scenario A: Traditional Laparoscopic Valve Replacement
Here, your major costs are the Conmed laparoscopic instruments (reusable shafts, graspers, scissors), a Conmed cautery machine (like the System 2450) for hemostasis, and the valve itself. If you use the Conmed Airseal insufflation system, you maintain stable pneumoperitoneum for the thoracoscopic approach.
I priced out a case in January 2025: the per-case disposable cost (not including the valve) landed at roughly $850-$1,200, depending on whether we used advanced energy devices. The big savings come from the reusable instruments. Our OR team stopped using single-use laparoscopic tools in 2022 and switched to Conmed's reusable line. We calculated that saved us about $2,700 per month in consumable costs. Not huge, but it adds up.
Scenario B: Robotic Valve Replacement
The robotic system itself? That's a capital expenditure of $1.5M to $2.5M, plus a service contract of about $150K-$200K per year. Then there are the per-case disposables: the robotic arms, drapes, and cannulae. That adds $1,800 to $3,500 per case.
The surprising thing I learned the hard way: even if you go robotic, you still need Conmed laparoscopic instruments in the room as backup. In September 2022, we had a robotic arm malfunction mid-case—the surgeon had to convert to manual laparoscopy. We scrambled to open a sterile backup set. If we hadn't had it ready, that patient would have been under anesthesia for another 45 minutes while we sourced instruments. That was a wake-up call.
Verdict on Cost:
For heart valve replacement specifically—a procedure where the traditional approach is already minimally invasive—the cost premium of robotics is hard to justify on a per-case basis. The Conmed laparoscopic instruments and cautery systems handle this well at a fraction of the cost. That said, if your hospital plans to use the robot for 400+ cases per year across multiple specialties (prostate, gynecology, thoracic), the economics shift. But for a valve-only service line? The math doesn't work.
Dimension 2: Training Burden – The Hidden Bottleneck
Scenario A: Traditional Laparoscopy with Conmed Instruments
Every general surgery resident and cardiothoracic fellow already learns basic laparoscopy. The instruments from Conmed—their graspers, dissectors, and the Smart Nail for tissue fixation—are intuitive. The Conmed Smart Nail technique, specifically, requires about 2-3 proctored cases before a surgeon feels comfortable deploying it. That's it.
At our institution, we trained four surgeons on the Smart Nail technique over two months. The biggest issue? Remembering to check the battery on the deployment handle. (One of our scrub techs created a pre-op checklist after a delayed deployment in November 2023. We've since avoided that particular headache.)
Scenario B: Robotic Surgery
Robotic training is a beast. The surgeon needs 8-12 hours of simulation, then 2-4 proctored cases. The OR team—scrub techs, circulators, anesthesia—all need dedicated training. And robotic proficiency fades. If your surgeons only do 1-2 robotic cases per month, they never get fluent.
I coordinated the training schedule for our robotic launch in early 2024. We had surgeons who were brilliant open surgeons struggle with robotic instrument articulation for weeks. That's not a dig at them—it's a fundamentally different motor skill.
Here's where the Conmed Smart Nail surgical technique actually shines in the traditional setting: the learning curve is shallow. It's an intuitive deployment tool for hernia mesh or soft tissue fixation. In the robotic setting, deploying the Smart Nail through the console adds an extra layer of cognitive load—the surgeon has to think about 'which port do I use for the Smart Nail?' instead of just 'hand me the nailer.'
Verdict on Training:
For a department that wants to be operational quickly, traditional laparoscopy with Conmed instruments wins. The training cost is lower, and the team can get to proficiency in weeks, not months. Robotic training is a long-term investment that only pays off with high case volume.
Dimension 3: Case Versatility – When the Robot Actually Helps
This is where I have to admit my bias got challenged.
I spent most of my career thinking 'robot is a luxury we don't need.' When we evaluated it, I was the skeptic in the room. But after watching five robotic cases (including two valve repairs and three prostatectomies), I changed my mind. Not entirely—but I had to acknowledge the robot's real advantage: suturing in tight spaces.
Scenario A: Traditional Laparoscopy
With Conmed laparoscopic instruments and their endoscopy systems, you get excellent visualization. The Conmed System 5000 gives you high-def imaging and can be used for both laparoscopic and thoracoscopic approaches. But the instruments are straight-shafted. Angled suturing inside the chest? That's tough. The surgeon has to rely on patient positioning and creative port placement.
Scenario B: Robotic Surgery
For heart valve repair—especially mitral valve—the robot's wristed instruments give the surgeon the ability to suture in ways that mimic the open technique, but through 1cm incisions. For complex repairs (e.g., leaflet prolapse with chordal reconstruction), this is a game-changer. The Conmed Smart Nail can be used to fix mesh or reinforce tissue, but the real magic of the robot for valves is the needle-driving.
Counterintuitive finding: for simple valve replacements, the robot adds little. The surgeon is essentially removing the native valve and seating a new one. That step doesn't require wristed instruments. It requires exposure and stability, which the Conmed endoscopy system provides just as well.
Verdict on Versatility:
For complex valve repairs, the robot has a genuine advantage. For simple valve replacements or standard MICS (minimally invasive cardiac surgery), Conmed laparoscopic instruments and optics do the job at a fraction of the cost. The magic is in knowing which patient and procedure type benefits.
So, What Should You Choose? (The Practical Answer)
I can't tell you what's right for your hospital. But I can tell you what I've seen work—and fail—in practice.
Go with Traditional Laparoscopy + Conmed Instruments if:
- Your cardiac volume is moderate (50-150 valve cases per year).
- You want to build a program quickly without a 12-month capital approval cycle.
- Your surgeons already do MICS with Conmed endoscopy and cautery systems—they'll be productive immediately.
- You're looking for a lower per-case cost structure.
Invest in Robotic Surgery (as a complement) if:
- You do 200+ valve repairs per year, especially complex mitral cases.
- You have the volume to amortize the capital cost across multiple specialties.
- You have a dedicated team that can maintain robotic proficiency.
- You accept that the first 6 months will be a financial drag as the team climbs the learning curve.
For most mid-sized hospitals I've worked with, the smartest path is: build your foundation with high-quality laparoscopic instruments from Conmed, train your team on MICS, and then—if volume supports it—add a robotic program as a specialized tool for complex cases. Don't go all-in on the robot thinking it replaces the need for skilled hands and good basic instruments. It doesn't.
Also worth considering: portable oxygen concentrators aren't directly relevant to this conversation, but I've had surgeons ask me about them for post-op recovery rooms. If you're setting up a step-down unit for cardiac patients, look at models that deliver at least 5 LPM continuous flow. That's a whole separate procurement rabbit hole I went down in Q4 2024.
Full disclosure: I'm an end-user and procurement specialist, not a Conmed employee. The pricing data mentioned was accurate as of January 2025. Verify current pricing directly with Conmed or your distributor. My opinions are based on my own experience coordinating surgical procurement for a 400-bed community hospital. Your situation may differ if you're in a different setting or have different case volumes.